UCSF neurosurgeons and an MRI physicist have pioneered a faster, more accurate and less invasive surgical technique for treating patients with movement disorders, potentially changing the future of neurosurgery.
February 03, 2011
January 18, 2011
UCSF researchers have tackled a decade-long scientific conundrum, and their discovery is expected to lead to significant advances in using stem cells to treat genetic diseases before birth.
November 30, 2010
Richard Abbott, MD, won an award for excellence in ophthalmology in the Asia-Pacific region following work to promote uniform global standards for eye care.
September 28, 2010
Surgical patients with known heart disease risks who are given beta blockers around the time of surgery have a significantly reduced risk of post-operative death compared with patients not given beta blockers, according to a study by researchers at the San Francisco VA Medical Center.
August 05, 2010
Surgery for localized prostate cancer offers a significantly higher survival rate than either external-beam radiation or hormonal therapies, according to a new study led by researchers at UCSF.
August 03, 2010
UCSF has challenged Stanford in a competition to register organ, eye and tissue donors that runs throughout the month of August.
May 20, 2010
Mitchell Cohen, MD, UCSF assistant professor of surgery, has received a $225,000 research grant from the National Trauma Institute to investigate the timing and mechanism of traumatic coagulopathy.
March 31, 2010
In April 2010, personnel aboard the International Space Station plan to carry out an experiment designed by a San Francisco VA Medical Center researcher that will investigate why the immune system’s T cells stop working in the absence of gravity. The experiment has implications for understanding the body’s ability to mount an immune response on earth, as well.
March 24, 2010
The occurrence of an unusual type of fracture of the femur, or the thigh bone, is very low in patients with osteoporosis, including those treated with the drug family known as bisphosphonates, according to a new study led by a team of UCSF epidemiologists.
March 18, 2010
Taking an innovative path toward personalized medicine, scientists for the first time will be able to eliminate – at an early point in a clinical trial — experimental drugs that show poor efficacy, dramatically shortening the time it takes to get the right medication to the right patient with breast cancer.